Bio Green Med Solution (bgms 6 Perp)Preferred / convertible
13F holders, Q4 2024 (December 31)2holders +1
1new positions
0sold out
$7.29avg. 13F price*
At the end of Q4 2024, 2 institutions reported holding Bio Green Med Solution (bgms 6 Perp) in their 13F filings, up 1 from Q3 2024. 1 opened new positions and 0 sold out. The largest holders were Sound Income Strategies, LLC ($685) and UBS Group AG ($612).
- Company
- Bio Green Med Solution (bgms 6 Perp)
- Filed as
- CYCLACEL PHARMACEUTICALS INC (Q4 2024)
- CUSIP
- 23254L207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $612 |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 84 shares bought, net +84 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Sound Income Strategies, LLC | — | No change | 94 | $685 |
| UBS Group AG | — | New | 84 | $612 |
"% of holder's portfolio" is BIO GREEN MED SOLUTION (BGMS 6 PERP)'s weight in each manager's 13F, not the share of Bio Green Med Solution (bgms 6 Perp) the manager owns.